Viemed Healthcare, Inc. has reported its financial results for the three months ended March 31, 2024. Net revenues for the quarter ended March 31, 2024 were $50.6 million, representing an increase of $11.0 million, or 28%. Net income for the quarter totaled $1.6 million. Adjusted EBITDA for the quarter ended March 31, 2024 totaled $10.1 million, a 21% increase. As of March 31, 2024, the company maintains a strong cash balance of $7.3 million and an overall working capital balance of $8.5 million. Long-term debt as of March 31, 2024 amounted to $5.9 million.

Viemed Healthcare, Inc., a client of our Bristol Investor Relations company, is a national leader in respiratory care and technology-enabled home medical equipment services.

Read the full press release here: Viemed Healthcare Announces First Quarter 2024 Financial Results